Find clinical trials for Asthma in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Warszawa, Mazowieckie, POL:
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Warsaw, Poland and 331 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Piaseczno, Poland and 314 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Warszawa, Poland and 84 other locations
The goal of this clinical trial\] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥...
Phase 3
Piaseczno, Poland and 62 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Warsaw, Poland and 68 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Warszawa, Poland and 382 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Warszawa, Poland and 361 other locations
expiratory volume (FEV1) \[PC20\]) of salbutamol administered via MDI with salbutamol HFA-134a or salbutamol HFA-152a in participants with mild asthma...
Phase 1
Jozefow, Poland and 9 other locations
birch pollen-induced allergic rhinoconjunctivitis, with or without asthma, when treated before and during the pollen season.Approximately 69...
Phase 3
Warsaw, Poland and 61 other locations
months.Trial population: Patients (18-65 years of age) suffering from moderate to severe ARC induced by HDM with or without controlled asthma...
Phase 3
Warszawa, Poland and 67 other locations
Clinical trials
Research sites
Resources
Legal